vimarsana.com

Page 4 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் வழிநடத்தியது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Countries weigh mix and match COVID-19 vaccines

    Reuters Published: 24 May 2021 08:55 PM BdST Updated: 24 May 2021 08:55 PM BdST A medical worker administers a dose of the Comirnaty Pfizer-BioNTech COVID-19 vaccine in a vaccination center in Paris as part of the coronavirus disease (COVID-19) vaccination campaign in France, May 12, 2021. REUTERS A growing number of countries are looking at switching to different COVID-19 vaccines for second doses amid supply delays and safety concerns that have slowed their vaccination campaigns. ); } The following are countries that are weighing, or have decided to adopt, such a solution: CANADA Officials said in May that people who were inoculated with AstraZeneca s COVID-19 shot may be offered a second dose of another vaccine, a move based on supply concerns as well as the rise in incidence of rare blood clots linked to first doses produced by the A

AstraZeneca COVID-19 vaccine Vaxzevria authorised for emergency use in Japan

FACTBOX-Countries weigh mix and match COVID-19 vaccines

FACTBOX-Countries weigh mix and match COVID-19 vaccines Reuters 2 hrs ago May 20 (Reuters) - A growing number of countries are looking at switching to different COVID-19 vaccines for second doses than were used for the first amid supply delays and safety concerns that have slowed their vaccination campaigns. Several medical studies to test the efficacy of switching COVID-19 vaccines are underway. The following are countries that are weighing, or have decided to adopt, such a solution: CANADA Officials said in May https://www.ctvnews.ca/health/coronavirus/canada-could-be-mixing-and-matching-covid-19-vaccines-by-the-summer-tam-1.5425807 that people who were inoculated with AstraZeneca s COVID-19 shot may be offered a second dose of another vaccine, a move based on supply concerns as well as the rise in incidence of rare blood clots linked to first doses produced by the Anglo-Swedish drugmaker.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.